Neonatal sepsis is a leading cause of neonatal mortality. Congenital heart disease accounts for additional risk of sepsis in neonates. Here we report a case of Down's syndrome with late onset neonatal sepsis associated with multiple superficial skin abscesses simulating staphylococcal infection. The baby was empirically treated with vancomycin. Subsequently, multidrug resistant Klebsiella pneumoniae was detected from both pus and blood culture. Change to appropriate antibiotic resulted in clinical recovery. Although sepsis is one of the major ailments in neonates, atypical presentations of neonatal sepsis in Down's syndrome patients are underreported. Here we highlight the atypical presentation of Klebsiella sepsis and the importance of early antibiogram in such cases.
Implications for Practice
1. Down's syndrome affects one out of 800 newborns worldwide. 1 Neonatal sepsis is a leading cause of neonatal mortality accounting for 12% of total neonatal deaths in India. 2 The presence of sepsis increases mortality during the first year of life in Down's syndrome patients. Infants with CHD (Congenital heart disease) have a higher incidence of culture proven sepsis and mortality. 3 
Case details
A 30-year-old lady delivered a 2.8kg male baby by Caesarean section and was referred to our institute on the eighth postnatal day for diagnosis and management of congenital defects. On admission, the newborn presented with mongoloid facies, short neck with loose skin, depressed bridge of nose and decreased muscle tone. A soft ejection systolic murmur was audible over apical and pulmonary areas. Subsequently it was found to be due to mild atrial septal defect by echocardiography. It was clinically diagnosed as Down's syndrome with acyanotic congenital heart disease. No other congenital defects were detected in clinical examination and laboratory 11, 12 Hence, it was initially suspected to be staphylococcal infection and empirical vancomycin therapy was also started. Later, the pus culture and sensitivity report confirmed that the causative agent was K. pneumoniae. The same strain of K. pneumoniae was isolated from blood culture with same resistance pattern.
Furthermore, K. pneumoniae is well recognised for multidrug resistance and outbreak potential in nurseries. Our finding in this patient corroborates with other studies. ESBL production was detected in 32-92% isolates of K. pneumoniae from neonatal sepsis where only treatment option was carbopenem or higher aminoglycoside. 4, 13 Down's syndrome affects one per 800 newborns. 1 The high mortality of 25-30% reported among Down's patients during the first year of life is mostly associated with severe conditions like congenital heart disease, bronchopneumonia and sepsis. 1 CHD is reported in 40-50% of Down's patients.
Endocardial cushion defect, atrial and ventricular septal defect, Fallot's tetralogy and patent ductus arteriosus are most commonly encountered heart malformation. 1 In addition, infants with CHD have a higher incidence of culture proven sepsis and mortality. 3 Intrinsic defect of the immune system may be related to increased risk of neonatal sepsis in Down's patients who suffer from T and B cell lymphopenia, impaired T and B cell response and defects of neutrophil chemotaxis from the very beginning of their life. 14, 15 Although, K. pneumoniae have been implicated as a major agents of LONS in Down's syndrome, 5 no correlation has been established between K. pneumoniae sepsis and Down's syndrome. Therefore, our finding may be coincidental and needs further studies. However, here we addressed the atypical presentation of neonatal sepsis and the diagnostic difficulty arising from it.
In conclusion, we have reported a rare case of neonatal sepsis in absence of typical symptoms in a newborn with Down's syndrome. Laboratory test was critical to diagnose the condition in this case. Congenital heart disease in neonates with Down syndrome should also be considered as an additional risk factor for neonatal sepsis.
